Abstract
Immunotherapy may be an effective treatment for neuroblastoma. It is of importance to delineate changes in various parameters of tumor immunity over an extended period, before and during the course of treatment, in any given case. In our patients with neuroblastoma, tumor-associated cell-mediated immune-reaction showed a good responsiveness before treatment. However, delayed cutaneous hypersensitivity reactions were shown to be negative in many cases, particularly in those with advanced tumor, and Tγ cells were enormously increased in some cases. During the course of therapy, the tumor-associated cellular immune responsiveness showed a tendency to become negative when the patient was tumor free or was in remission, but showed a tendency to become positive on regrowth, recurrence or metastasis of tumor. The Tγ cells showed much the same fluctuations as did the tumor-associated cellular immune responsiveness.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bill A, Morgan A. Evidence for immune reactions to neuroblastoma and future possibilities for investigation. J Pediat Surg 1970; 5: 111–116.
Helson L, Ramos C, Oettgen H, Murphy M. DNCB reactivity in children with neuroblastoma. Proc Amer Assoc Cancer Research 1971; 12: 86–86.
Helson H, Shou L, Tauber J. Lymphocyte transformation in children with neuroblastoma. J Natl Cancer Inst 1976; 57: 721–724.
Hellström I, Hellström K, Pierce G, Bill A. Demonstration of cell-bound and humoral immunity against neuroblastoma cells. Proc Natl Acad Sci U.S.A. 1968; 60: 1231–1238.
Hellström I, Hellström K, Bill A, Pierce G, Yang J. Studies on cellular immunity to human neuroblastoma cells. Int J Cancer 1970; 6: 172–188.
Fujii G, Nishihira T, Osada I, Sekiguchi M. Mixed lymphoid cell-tumor culture reaction. Jpn J Exp Med 1974; 44: 347–357.
Fujii G, Sekiguchi M, Miyamoto H, Suzuki K, Sudo K. Lymphocyte responses to autochthonous tumorsin vitro. Gan no rinsho 1976; 22: 714–718. (in Japanese)
Evans AE, D'Angio GJ, Randolph J. A proposed staging for children with neuroblastoma. Cancer 1971; 27: 374–378.
Kurosu Y, Yasushi E, Morita K. IgG-Fc receptor positive T cells in the peripheral blood of gastric cancer patients. Nihon U J Med 1982; 24: 69–79.
Shinbo T, Mugitani H, Sugahara M, Kakihira M, Yata J. Abnormalities of lymphocytes and macrophages in cancer patients. Cancer and Chemotherapy 1978; 5: 261–272. (in Japanese)
Yasui E. Immune status of tract cancer patients: Changes in IgG-Fc receptor positive T cells values before and after surgical treatment. Nichidai Igaku Zasshi 1981; 40: 591–601. (in Japanese)
Honjo H. Studies on lymphocyte proliferative responses to autologous tumor extract in various cancer patients. Nichidai Igaku Zasshi 1981; 40: 129–139. (in Japanese)
Kurosu Y, Honjo H, Morita K. Lymphocyte proliferative response to autochthonous tumor extract in patients with various types of cancers. Jpn J Clin oncol 1982; 12: 213–218.
Kurosu Y, Hironaka T, Sunaga S, Okabe I, Morita K. Mixed lymphocyte-tumor cell cultures in patients with various childhood malignant solid tumors. Nihon U J Med 1977; 19: 247–255.
Hironaka T. Cell mediated immunoreactions to various histological types of human solid tumors:in vitro detection by mixed lymphocyte-tumor cell culture. Nichidai Igaku Zasshi 1979; 38: 311–323. (in Japanese)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Okabe, I., Kurosu, Y. & Morita, K. Cell-mediated immune reactions to clinical neuroblastoma. The Japanese Journal of Surgery 15, 368–374 (1985). https://doi.org/10.1007/BF02469932
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02469932